Madrigal Pharmaceuticals Statistics
Total Valuation
MDGL has a market cap or net worth of $9.30 billion. The enterprise value is $8.70 billion.
| Market Cap | 9.30B |
| Enterprise Value | 8.70B |
Important Dates
The last earnings date was Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MDGL has 23.23 million shares outstanding. The number of shares has decreased by -13.52% in one year.
| Current Share Class | 23.23M |
| Shares Outstanding | 23.23M |
| Shares Change (YoY) | -13.52% |
| Shares Change (QoQ) | +31.38% |
| Owned by Insiders (%) | 5.22% |
| Owned by Institutions (%) | 71.55% |
| Float | 13.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 106.38 |
| PS Ratio | 6.51 |
| Forward PS | 4.59 |
| PB Ratio | 14.83 |
| P/TBV Ratio | 15.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.05, with a Debt / Equity ratio of 0.56.
| Current Ratio | 3.05 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.56 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.75 |
Financial Efficiency
Return on equity (ROE) is -24.82% and return on invested capital (ROIC) is -9.77%.
| Return on Equity (ROE) | -24.82% |
| Return on Assets (ROA) | -6.82% |
| Return on Invested Capital (ROIC) | -9.77% |
| Return on Capital Employed (ROCE) | -15.57% |
| Weighted Average Cost of Capital (WACC) | -0.93% |
| Revenue Per Employee | $1.56M |
| Profits Per Employee | -$169,905 |
| Employee Count | 915 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.89% in the last 52 weeks. The beta is -1.00, so MDGL's price volatility has been lower than the market average.
| Beta (5Y) | -1.00 |
| 52-Week Price Change | -2.89% |
| 50-Day Moving Average | 492.40 |
| 200-Day Moving Average | 498.58 |
| Relative Strength Index (RSI) | 23.99 |
| Average Volume (20 Days) | 498,926 |
Short Selling Information
The latest short interest is 2.19 million, so 9.45% of the outstanding shares have been sold short.
| Short Interest | 2.19M |
| Short Previous Month | 2.40M |
| Short % of Shares Out | 9.45% |
| Short % of Float | 15.99% |
| Short Ratio (days to cover) | 7.90 |
Income Statement
In the last 12 months, MDGL had revenue of $1.43 billion and -$155.46 million in losses. Loss per share was -$6.73.
| Revenue | 1.43B |
| Gross Profit | 1.30B |
| Operating Income | -152.65M |
| Pretax Income | -155.46M |
| Net Income | -155.46M |
| EBITDA | -151.10M |
| EBIT | -152.65M |
| Loss Per Share | -$6.73 |
Balance Sheet
The company has $960.97 million in cash and $354.22 million in debt, with a net cash position of $606.75 million or $26.12 per share.
| Cash & Cash Equivalents | 960.97M |
| Total Debt | 354.22M |
| Net Cash | 606.75M |
| Net Cash Per Share | $26.12 |
| Equity (Book Value) | 626.94M |
| Book Value Per Share | 27.00 |
| Working Capital | 932.87M |
Cash Flow
In the last 12 months, operating cash flow was -$157.01 million and capital expenditures -$11.64 million, giving a free cash flow of -$168.65 million.
| Operating Cash Flow | -157.01M |
| Capital Expenditures | -11.64M |
| Depreciation & Amortization | 1.55M |
| Net Borrowing | n/a |
| Free Cash Flow | -168.65M |
| FCF Per Share | -$7.26 |
Margins
Gross margin is 90.96%, with operating and profit margins of -10.69% and -10.89%.
| Gross Margin | 90.96% |
| Operating Margin | -10.69% |
| Pretax Margin | -10.89% |
| Profit Margin | -10.89% |
| EBITDA Margin | -10.58% |
| EBIT Margin | -10.69% |
| FCF Margin | n/a |
Dividends & Yields
MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 13.52% |
| Shareholder Yield | 13.52% |
| Earnings Yield | -1.68% |
| FCF Yield | -1.81% |
Analyst Forecast
The average price target for MDGL is $686.06, which is 71.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $686.06 |
| Price Target Difference | 71.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (3Y) | 44.42% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MDGL has an Altman Z-Score of 7.92 and a Piotroski F-Score of 1.
| Altman Z-Score | 7.92 |
| Piotroski F-Score | 1 |